Drs. Leora Horn, Ben Solomon, & Jack West consider whether third generation EGFR TKIs, so active in patients with acquired resistance, might be best used prior to development of acquired resistance.
Should Third Generation EGFR Inhibitors Be Used Before or After Progression_ [360p]
